Atlantic Pharma Holdings
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
48/100
Moderate Influence
$3.2M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Atlantic Pharma Holdings reported $3.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
US Trade Representative
Dept of Interior
Dept of State
White House
Dept of Agriculture
Dept of Housing & Urban Development
Centers for Medicare & Medicaid Services
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | BGR Group LLP | HCRPOS | 1 | $206K |
| 2020 Apr-Jun | Holland & Knight LLP | AERPHA | 1 | $202K |
| 2020 Jul-Sep | Covington & Burling LLP | POSMEDHCR+2 | 1 | $138K |
| 2020 Oct-Dec | K&L Gates LLP | AERPHA | 1 | $238K |
| 2021 Jan-Mar | K&L Gates LLP | MED | 1 | $82K |
| 2021 Apr-Jun | Brownstein Hyatt LLP | GOVPHAPOS+1 | 1 | $82K |
| 2021 Jul-Sep | Holland & Knight LLP | PHA | 1 | $121K |
| 2021 Oct-Dec | K&L Gates LLP | HCRMEDPOS | 1 | $87K |